Precision BioSciences Controller resigns; CFO Kelly named principal accounting officer

PRECISION BIOSCIENCES INC

Shane Barton resigned as VP and Corporate Controller, effective Sept 15, 2023.
CFO Alex Kelly appointed as principal accounting officer effective Sept 15, 2023.
Senior Director Mei Burris to assume responsibilities previously held by Barton.
Mei Burris is a CPA with prior roles at Heat Biologics and Cempra Pharmaceuticals.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Shane Barton

Vice President and Corporate Controller

DTIL · PRECISION BIOSCIENCES INC

Effective: 2023-09-15
Filed: September 7, 2023, 7:59 PM ET

On August 31, 2023, Shane Barton notified Precision BioSciences, Inc. (the “Company”) of his resignation as the Company’s Vice President and Corporate Controller, effective September 15, 2023

Role change

Alex Kelly

Chief Financial Officer and Principal Accounting Officer

DTIL · PRECISION BIOSCIENCES INC

Effective: 2023-09-15
Filed: September 7, 2023, 7:59 PM ET

On September 6, 2023, the Company’s Board of Directors designated Alex Kelly, the Company’s Chief Financial Officer and principal financial officer, to also serve as the Company’s principal accounting officer effective upon Mr. Barton’s departure.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Shane Barton resigned as Vice President and Corporate Controller at PRECISION BIOSCIENCES INC.

Action: resigned
Role: Vice President and Corporate Controller

Exact text from the filing

On August 31, 2023, Shane Barton notified Precision BioSciences, Inc. (the “Company”) of his resignation as the Company’s Vice President and Corporate Controller, effective September 15, 2023

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Alex Kelly changed role as Chief Financial Officer and Principal Accounting Officer at PRECISION BIOSCIENCES INC.

Action: designated
Role: Chief Financial Officer and Principal Accounting Officer

Exact text from the filing

On September 6, 2023, the Company’s Board of Directors designated Alex Kelly, the Company’s Chief Financial Officer and principal financial officer, to also serve as the Company’s principal accounting officer effective upon Mr. Barton’s departure.

View on SEC.gov

PRECISION BIOSCIENCES INC filing history →

Source: SEC EDGAR

accession 0000950170-23-046872

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.